1. Home
  2. PBHC vs ADVM Comparison

PBHC vs ADVM Comparison

Compare PBHC & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBHC
  • ADVM
  • Stock Information
  • Founded
  • PBHC 1859
  • ADVM 2006
  • Country
  • PBHC United States
  • ADVM United States
  • Employees
  • PBHC N/A
  • ADVM N/A
  • Industry
  • PBHC Major Banks
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PBHC Finance
  • ADVM Health Care
  • Exchange
  • PBHC Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • PBHC 92.9M
  • ADVM 94.6M
  • IPO Year
  • PBHC N/A
  • ADVM 2014
  • Fundamental
  • Price
  • PBHC $15.14
  • ADVM $4.21
  • Analyst Decision
  • PBHC
  • ADVM Buy
  • Analyst Count
  • PBHC 0
  • ADVM 5
  • Target Price
  • PBHC N/A
  • ADVM $16.60
  • AVG Volume (30 Days)
  • PBHC 6.2K
  • ADVM 989.0K
  • Earning Date
  • PBHC 10-31-2025
  • ADVM 11-07-2025
  • Dividend Yield
  • PBHC 2.64%
  • ADVM N/A
  • EPS Growth
  • PBHC N/A
  • ADVM N/A
  • EPS
  • PBHC 0.28
  • ADVM N/A
  • Revenue
  • PBHC $39,015,000.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • PBHC N/A
  • ADVM $1,449.40
  • Revenue Next Year
  • PBHC N/A
  • ADVM N/A
  • P/E Ratio
  • PBHC $53.94
  • ADVM N/A
  • Revenue Growth
  • PBHC N/A
  • ADVM N/A
  • 52 Week Low
  • PBHC $13.55
  • ADVM $1.78
  • 52 Week High
  • PBHC $18.53
  • ADVM $8.18
  • Technical
  • Relative Strength Index (RSI)
  • PBHC 50.29
  • ADVM 49.22
  • Support Level
  • PBHC $14.65
  • ADVM $3.98
  • Resistance Level
  • PBHC $15.20
  • ADVM $4.29
  • Average True Range (ATR)
  • PBHC 0.18
  • ADVM 0.34
  • MACD
  • PBHC -0.04
  • ADVM -0.09
  • Stochastic Oscillator
  • PBHC 82.44
  • ADVM 27.97

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: